Skip to main content

Find Clinical Trials

Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,982 public trials 1,832 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease

NCT07187167

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Non-Langerhans-Cell, +3 more
Locations: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Recruiting

Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH

NCT07187193

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Recruiting

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

NCT04083495

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States

Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States

View Trial Details

Recruiting

A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

NCT03248310

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Lymphedema
Locations: Memorial Sloan Kettering Westchester (Limited Protocol Activities) Harrison, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

Memorial Sloan Kettering Nassau (Limited Protocol Activites) Rockville Centre, New York, United States

View Trial Details

Recruiting

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

NCT06120166

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Recruiting

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma

NCT07011056

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: West China Hospital Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)

NCT06234384

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +4 more
Locations: Foundation For Sarcoidosis Research Chicago, Illinois, United States

View Trial Details

Recruiting

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

NCT04079179

Conditions: Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +18 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

Children's Hospital of Orange County Orange, California, United States

UCSF Benioff Children's Hospital San Francisco, California, United States

View Trial Details

Recruiting

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

NCT05643235

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Blood Protein Disorders, +35 more
Locations: Northwell (Northshore University/Long Island Jewish Hospitals) New Hyde Park, New York, United States

View Trial Details

Recruiting

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

NCT05223413

Conditions: Anthracycline-induced Cardiac Toxicity, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Aarhus University Aarhus, Denmark

Hospital Jaques Monod, El Havre Montivilliers, France

Henri Becquerel Rouen, France

University Hospital Duesseldorf UDUS Düsseldorf, Germany

View all 24 locations

View Trial Details